RESUMO
A patient with hematuria was shown to have thymine-uraciluria. The dihydropyrimidine dehydrogenase (DPD) activity in peripheral blood mononuclear cells was 0.16 nmol/mg/h; controls: 9.9 +/- 2.8 nmol/mg/h. Analysis of DPYD showed that the patient was compound heterozygous for the novel mutations 237C > A (C79X) in exon 4 and 704G > A (R235Q) in exon 7. The nonsense mutation (C79X) leads to premature termination of translation and thus to a non-functional protein. Analysis of the crystal structure of pig DPD suggested that the R235Q mutation might interfere with the binding of FAD and the electron flow between the NADPH and the pyrimidine substrate site of DPD.
Assuntos
Di-Hidrouracila Desidrogenase (NADP)/genética , Hematúria/enzimologia , Hematúria/genética , Mutação de Sentido Incorreto , Mutação Puntual , Adulto , Animais , Criança , Cristalografia por Raios X , Di-Hidrouracila Desidrogenase (NADP)/química , Di-Hidrouracila Desidrogenase (NADP)/metabolismo , Feminino , Genótipo , Hematúria/patologia , Humanos , Masculino , Modelos Moleculares , Conformação Proteica , SuínosRESUMO
The proposed metabolic advantage of 6-thioguanine (6-TG) is the direct conversion into the pharmacologically active 6-thioguaninenucleotides (6-TGN). The authors assessed metabolic characteristics of 6-TG treatment in patients with Crohn's disease (N = 7) on therapy with 20 mg 6-TG. 6-thioguanine-monophosphate (6-TGMP), 6-thioguanine-diphosphate (6-TGDP), and 6-thioguanine-triphosphate (6-TGTP) were measured by high-performance liquid chromatography analysis in erythrocytes. Thiopurine S-methyltransferase activity and total 6-TGN levels were determined by standard methods. High interindividual variance in metabolite measurements was observed. Main metabolites were 6-TGTP (median = 531 pmol/8 x 10(8) red blood cells) and 6-TGDP (median = 199 pmol/8 x 10(8) red blood cells). Traces of 6-TGMP (median = 39 pmol/8 x 10(8) red blood cells) and 6-TG (2 patients) could be detected. 6-TGN levels correlated with 6-TGTP levels (r = 0.929, P = .003) and with the sum of separate nucleotides (r = 0.929, P = .003). No correlations were established between TPMT activity (median = 13 pmol/h/10(7)) and 6-TG metabolites. The 1-step metabolism of 6-TG still leads to high interindividual variance in metabolite concentrations. Total 6-TGN level monitoring may suffice for clinical practice.
Assuntos
Doença de Crohn/sangue , Nucleotídeos de Guanina/sangue , Imunossupressores/farmacocinética , Tioguanina/farmacocinética , Tionucleotídeos/sangue , Adulto , Doença de Crohn/tratamento farmacológico , Eritrócitos/metabolismo , Feminino , Humanos , Imunossupressores/uso terapêutico , Masculino , Pessoa de Meia-Idade , Tioguanina/uso terapêuticoRESUMO
Isolated sulfite oxidase deficiency is an autosomal recessive, neurological disorder resulting from a defect in SUOX, the gene encoding the enzyme that catalyzes the terminal reaction in the sulfur amino acid degradation pathway. In its classical, severe form, sulfite oxidase deficiency leads to intractable seizures, severe and progressive brain pathology and death at an early age. We report here on clinical features and mutational analysis of the genetic defect in a newborn with sulfite oxidase deficiency. Cultured fibroblasts from this patient exhibited no detectable sulfite oxidase activity, and a unique four base pair deletion was present in the cDNA isolated from the same source. Identification of the same genetic defect in a heterozygous state in each of the parents and the monitoring of subsequent pregnancies in this family by DNA-based prenatal diagnosis are also described. The deletion mutation was identified in a homozygous state in uncultured chorionic villus tissue from the second pregnancy that was subsequently terminated. In the third pregnancy, the presence of sulfite oxidase activity and identification of the mutation in a heterozygous state suggested that the fetus was not affected. This pregnancy resulted in the birth of a normal child.
Assuntos
Encefalopatias Metabólicas Congênitas/genética , Análise Mutacional de DNA , Mutação , Oxirredutases atuantes sobre Doadores de Grupo Enxofre/deficiência , Oxirredutases atuantes sobre Doadores de Grupo Enxofre/genética , Encéfalo/anormalidades , Células Cultivadas , Vilosidades Coriônicas/enzimologia , Amostra da Vilosidade Coriônica , DNA Complementar/análise , Feminino , Fibroblastos/enzimologia , Deleção de Genes , Humanos , Recém-Nascido , Imageamento por Ressonância Magnética , Reação em Cadeia da Polimerase , GravidezRESUMO
Voltage-dependent anion channels (VDACs), also known as mitochondrial porins, are small channel proteins involved in the translocation of metabolites across the mitochondrial outer membrane. A single channel-forming protein is found in yeast, whereas higher eukaryotes express multiple VDACs, with humans and mice each harboring three distinct channels (VDAC1-3) encoded by separate genes. To begin to assess the functions of each of the three isoforms, the VDAC3 gene was inactivated by targeted disruption in embryonic stem cells. Here we show that mice lacking VDAC3 are healthy, but males are infertile. Although there are normal sperm numbers, the sperm exhibit markedly reduced motility. Structural defects were found in two-thirds of epididymal axonemes, with the most common abnormality being loss of a single microtubule doublet at a conserved position within the axoneme. In testicular sperm, the defect was only rarely observed, suggesting that instability of a normally formed axoneme occurs with sperm maturation. In contrast, tracheal epithelial cilia showed no structural abnormalities. In addition, skeletal muscle mitochondria were abnormally shaped, and activities of the respiratory chain complexes were reduced. These results demonstrate that axonemal defects may be caused by associated nonaxonemal components such as mitochondrial channels and illustrate that normal mitochondrial function is required for stability of the axoneme.
Assuntos
Infertilidade Masculina/genética , Porinas/genética , Porinas/fisiologia , Motilidade dos Espermatozoides/genética , Motilidade dos Espermatozoides/fisiologia , Animais , Northern Blotting , Western Blotting , Transporte de Elétrons , Imuno-Histoquímica , Masculino , Camundongos , Microscopia Eletrônica , Mitocôndrias/metabolismo , Modelos Genéticos , Músculo Esquelético/metabolismo , Músculo Esquelético/ultraestrutura , Porinas/biossíntese , Isoformas de Proteínas , Contagem de Espermatozoides , Distribuição Tecidual , Canal de Ânion 1 Dependente de Voltagem , Canais de Ânion Dependentes de VoltagemRESUMO
UNLABELLED: The prerequisite for liver transplantation as a therapeutic option for inherited metabolic diseases should be that the enzyme defect, being responsible for the major clinical (hepatic and/or extra-hepatic) abnormalities, is localised in the liver. Furthermore, no adequate dietary or pharmacological treatment should be available or such treatment should have an unacceptable influence on the quality of life. We report an infant, who developed end-stage liver disease with persistent lactic acidaemia in his first months of life. Analysis of the mitochondrial respiratory chain in liver tissue revealed a combined partial complex I and IV deficiency. No extra-hepatic involvement could be demonstrated by careful screening for multiple organ involvement, including analysis of the mitochondrial respiratory chain in muscle tissue and cultured skin fibroblasts. The boy received a reduced size liver graft at the age of 8 months. He recovered successfully. Almost 5 years after transplantation he is in good clinical condition. No clinical or biochemical signs of any organ dysfunction have been demonstrated. The considerations on which basis it was decided that there was no contra-indication to perform liver transplantation in this patient are discussed. CONCLUSION: The possibility of a mitochondrial respiratory chain deficiency should be considered in liver disease of unknown origin prior to liver transplantation. Liver transplantation is a therapeutic option in mitochondrial respiratory chain deficiency-based end-stage liver disease provided that extra-hepatic involvement is carefully excluded.
Assuntos
Deficiência de Citocromo-c Oxidase , Falência Hepática/genética , Transplante de Fígado , Miopatias Mitocondriais/genética , NADH NADPH Oxirredutases/deficiência , Pré-Escolar , Contraindicações , Complexo I de Transporte de Elétrons , Seguimentos , Humanos , Lactente , Falência Hepática/cirurgia , Testes de Função Hepática , Masculino , Miopatias Mitocondriais/cirurgiaRESUMO
UNLABELLED: Pyruvate dehydrogenase (PDH) complex deficiency, a common cause of congenital lactic acidosis, is mostly due to mutations in the X-linked gene coding for the E1alpha subunit of the complex. We have studied two unrelated girls presenting a static encephalopathy with spastic quadriplegia, microcephaly and seizures and in one girl, hypocalcaemia, a new finding in PDH complex deficiency. PDH deficiency was diagnosed in adolescence and both girls had low PDH complex activity in muscle but normal amounts of all subunits on Western blotting, and a normal lactate/pyruvate ratio in blood and CSF. Mutation analysis of the E1alpha gene at the cDNA or DNA level revealed an arginine to histidine substitution at amino acid position 288 (R288H) in the girl with hypocalcaemia and a 12 bp insertion, predicting a four amino acid duplication at the c-terminal end of the protein in the second girl. They both carried a normal and a mutated E1alpha gene and X-inactivation studies showed skewed patterns. CONCLUSION: Mutation identification in pyruvate dehydrogenase complex deficiency remains important especially for the determination of the recurrence risk and for reliable genetic counselling in couples with an affected child.
Assuntos
Mutação , Piruvato Desidrogenase (Lipoamida) , Doença da Deficiência do Complexo de Piruvato Desidrogenase/genética , Complexo Piruvato Desidrogenase/genética , Acidose Láctica/etiologia , Adolescente , Western Blotting , Paralisia Cerebral/diagnóstico , Análise Mutacional de DNA , Diagnóstico Diferencial , Feminino , Ligação Genética , Humanos , Hipocalcemia/etiologia , Microcefalia/genética , Doença da Deficiência do Complexo de Piruvato Desidrogenase/diagnóstico , Quadriplegia/diagnóstico , Quadriplegia/genética , Cromossomo X/genéticaRESUMO
Pontocerebellar hypoplasias are congenital disorders of brain morphogenesis which include such diverse etiologies as carbohydrate-deficient glycoprotein syndrome type 1, cerebromuscular dystrophies (Walker-Warburg syndrome, Fukuyama syndrome, muscle-eye-brain disease) and at least two types of autosomal recessive neurodegenerations known as pontocerebellar hypoplasia type I and II. Pontocerebellar hypoplasia type 1 is a lethal phenotype and clinical features include congenital contractures, respiratory insufficiency, central and peripheral motor dysfunction and spinal anterior horn degeneration. Type 2 is characterized by progressive microcephaly, extrapyramidal dyskinesia and normal spinal cord findings. In this paper, we describe a girl, born at 33 weeks of gestation, presenting with respiratory insufficiency and multiple contractures. MRI scan of the brain demonstrated pontocerebellar hypoplasia and cortical and diffuse periventricular white matter abnormalities. Postmortem examination showed pontocerebellar hypoplasia with extensive gliosis of the periventricular white matter and of the basal ganglia with normal spinal cord findings. Histology of skeletal muscle was normal. Biochemical analysis demonstrated multiple deficiencies of respiratory chain enzymes in skin fibroblasts. This case demonstrates a lethal phenotype of pontocerebellar hypoplasia without spinal cord abnormalities associated with a respiratory-chain disorder. The diagnostic workup in a patient whose brain image shows pontocerebellar hypoplasia should include a search for respiratory-chain impairment.
Assuntos
Anormalidades Múltiplas , Erros Inatos do Metabolismo dos Carboidratos/diagnóstico , Cerebelo/anormalidades , Encefalomiopatias Mitocondriais/diagnóstico , Atrofias Olivopontocerebelares/congênito , Atrofias Olivopontocerebelares/diagnóstico , Ponte/anormalidades , Erros Inatos do Metabolismo dos Carboidratos/complicações , Cerebelo/patologia , Eletroencefalografia , Transporte de Elétrons , Evolução Fatal , Feminino , Gliose/patologia , Humanos , Recém-Nascido , Imageamento por Ressonância Magnética , Bulbo/anormalidades , Bulbo/patologia , Encefalomiopatias Mitocondriais/complicações , Atrofias Olivopontocerebelares/etiologia , Ponte/patologiaRESUMO
Eukaryotic porins or VDACs (Voltage-Dependent Anion-selective Channels) are integral membrane proteins forming large hydrophilic pores. Three functioning genes for VDAC isoforms have been detected in mouse and the corresponding cDNAs are known also in humans. Tissue-specific VDAC isoform 1 (HVDAC1) deficiency in human skeletal muscle is responsible of a rare mitochondrial encephalomyopathy, fatal in childhood. Since coding sequences are not affected in the patient, we focused our interest in the gene structure. HVDAC1 and 2 have been previously mapped at chromosomes Xq13-21 and 21, respectively. Screening of an human chromosome X cosmid library resulted only in the isolation of processed pseudogenes, finely mapped at Xq22 and Xp11.2. Here, we report the mapping of HVDAC1 to chromosome 5q31 and HVDAC2 to chromosome 10q22 by FISH. Exon/intron probes, designed on the basis of the mouse gene structures, were obtained by long extension PCR amplification using the whole genomic DNA as a template. The sequence of the probe extremities clearly pointed to a genuine VDAC genomic sequence. Human and mouse regions where VDAC 1 and 2 genes were mapped are known to be synthetic, thus reinforcing the mapping of the human homologues.
Assuntos
Mapeamento Cromossômico , Cromossomos Humanos Par 10/genética , Cromossomos Humanos Par 5/genética , Canais Iônicos/genética , Proteínas de Membrana/genética , Porinas , Éxons/genética , Humanos , Hibridização in Situ Fluorescente , Íntrons/genética , Encefalomiopatias Mitocondriais/genética , Pseudogenes/genética , Canal de Ânion 1 Dependente de Voltagem , Canais de Ânion Dependentes de VoltagemRESUMO
The authors report a child with a spinal muscular atrophy (SMA)-like picture, cardiomyopathy, and cytochrome c oxidase (COX) deficiency. Electromyography and muscle biopsy showed findings typical of SMA. However, COX staining of the muscle was negative. DNA analysis did not detect deletions in the survival motor neuron (SMN) gene. The lactate and lactate-to-pyruvate ratios were increased in blood and CSF. COX activity was decreased in muscle and fibroblasts. Western blot analysis showed reduced contents for all COX subunits. Patients with clinical features resembling SMA but with an intact SMN gene should be screened for a mitochondrial disorder.
Assuntos
Cardiomegalia/complicações , Deficiência de Citocromo-c Oxidase , Atrofias Musculares Espinais da Infância/complicações , Western Blotting , Cardiomegalia/enzimologia , Células Cultivadas , Fibroblastos/enzimologia , Fibroblastos/ultraestrutura , Humanos , Recém-Nascido , Ácido Láctico/metabolismo , Masculino , Mitocôndrias/enzimologia , Ácido Pirúvico/metabolismo , Atrofias Musculares Espinais da Infância/enzimologiaRESUMO
Five patients with diminished activity of complex III of the mitochondrial respiratory chain have been screened for mutations in the mitochondrial cytochrome b (cyt b) gene. In 1 patient, a young boy with an akinetic rigid syndrome and a mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS), a novel 4-base pair deletion was identified. This mutation in this highly conserved gene is considered to be pathogenic since it is a heteroplasmic frame shift mutation predicted to lead to a truncated protein.
Assuntos
Grupo dos Citocromos b/genética , Deleção de Genes , Síndrome MELAS/genética , Mitocôndrias/genética , Doença de Parkinson Secundária/genética , Adulto , Southern Blotting , Análise Mutacional de DNA , Complexo III da Cadeia de Transporte de Elétrons/genética , Humanos , Síndrome MELAS/complicações , Masculino , Fosforilação Oxidativa , Doença de Parkinson Secundária/complicações , FenótipoAssuntos
Acetil-CoA C-Aciltransferase/deficiência , Erros Inatos do Metabolismo dos Aminoácidos/diagnóstico , Metabolismo Energético , Isoleucina/metabolismo , Doenças Neurodegenerativas/etiologia , Erros Inatos do Metabolismo dos Aminoácidos/complicações , Erros Inatos do Metabolismo dos Aminoácidos/enzimologia , Células Cultivadas , Ácidos Dicarboxílicos/urina , Fibroblastos/enzimologia , Fumaratos/urina , Humanos , Lactente , Malatos/urina , Masculino , Fenótipo , Ácido Succínico/urinaRESUMO
Bovine NADH:ubiquinone oxidoreductase (complex 1) of the mitochondrial respiratory chain consists of about 36 nuclear-encoded subunits. We review the current knowledge of the 15 human complex I subunits cloned so far, and report the 598-bp cDNA sequence, the chromosomal localization and the tissue expression of an additional subunit, the B17 subunit. The cDNA open reading frame of B17 comprises 387 bp and encodes a protein of 128 amino acids (calculated Mr 15.5 kDa). There is 82.7% and 78.1% homology, respectively, at the cDNA and amino acid level with the bovine counterpart. The gene of the B17 subunit has been mapped to chromosome 2. Multiple-tissue dot-blots showed ubiquitous expression of the mRNA with relatively higher expression in tissues known for their high energy demand. Of these, kidney showed the highest expression. Mutational analysis of the subunit revealed no mutations or polymorphisms in 20 patients with isolated enzymatic complex I deficiency in cultured skin fibroblasts.
Assuntos
NADH NADPH Oxirredutases/genética , Animais , Sequência de Bases , Bovinos , Análise Mutacional de DNA , DNA Complementar , Complexo I de Transporte de Elétrons , Humanos , Dados de Sequência Molecular , Reação em Cadeia da Polimerase , Distribuição TecidualAssuntos
Acidose Láctica/tratamento farmacológico , Acidose Láctica/congênito , Acidose Láctica/enzimologia , Isótopos de Carbono , Radioisótopos de Carbono , Ácido Dicloroacético/uso terapêutico , Feminino , Humanos , Lactente , Imageamento por Ressonância Magnética , Monitorização Fisiológica/métodos , Doença da Deficiência do Complexo de Piruvato Desidrogenase/diagnósticoRESUMO
Mitochondrial transmembrane carrier deficiencies are a recently discovered group of disorders, belonging to the so-called mitochondriocytopathies. We examined the human tissue distribution of carriers which are involved in the process of oxidative phosphorylation (adenine nucleotide translocator, phosphate carrier, and voltage-dependent anion channel) and some mitochondrial substrate carriers (2-oxoglutarate carrier, carnitine-acylcarnitine carrier, and citrate carrier). The tissue distribution on mRNA level of mitochondrial transport proteins appears to be roughly in correlation with the dependence of these tissues on mitochondrial energy production capacity. In general the main mRNA expression of carriers involved in mitochondrial energy metabolism occurs in skeletal muscle and heart. Expression in liver and pancreas differs between carriers. Expression in brain, placenta, lung, and kidney is lower than in the other tissues. Western and Northern blotting experiments show a comparable HVDAC1 protein and mRNA distribution for the tested tissues. Patient's studies showed that cultured skin fibroblasts may not be a reliable alternative for skeletal muscle in screening for human mitochondrial carrier defects.
Assuntos
Proteínas de Transporte/metabolismo , Mitocôndrias/metabolismo , Porinas , Nucleotídeos de Adenina/metabolismo , Carnitina/metabolismo , Ácido Cítrico/metabolismo , Humanos , Ácidos Cetoglutáricos/metabolismo , Proteínas de Membrana/metabolismo , Fosfatos/metabolismo , Canal de Ânion 1 Dependente de Voltagem , Canais de Ânion Dependentes de VoltagemRESUMO
We have blocked creatine kinase (CK) mediated phosphocreatine (PCr) <==> ATP transphosphorylation in mitochondria and cytosol of skeletal muscle by knocking out the genes for the mitochondrial (ScCKmit) and the cytosolic (M-CK) CK isoforms in mice. Animals which carry single or double mutations, if kept and tested under standard laboratory conditions, have surprisingly mild changes in muscle physiology. Strenuous ex vivo conditions were necessary to reveal that MM-CK absence in single and double mutants leads to a partial loss of tetanic force output. Single ScCKmit deficiency has no noticeable effects but in combination the mutations cause slowing of the relaxation rate. Importantly, our studies revealed that there is metabolic and cytoarchitectural adaptation to CK defects in energy metabolism. The effects involve mutation type-dependent alterations in the levels of AMP, IMP, glycogen and phosphomonoesters, changes in activity of metabolic enzymes like AMP-deaminase, alterations in mitochondrial volume and contractile protein (MHC isoform) profiles, and a hyperproliferation of the terminal cysternae of the SR (in tubular aggregates). This suggests that there is a compensatory resiliency of loss-of-function and redirection of flux distributions in the metabolic network for cellular energy in our mutants.
Assuntos
Creatina Quinase/genética , Mitocôndrias Musculares/enzimologia , Músculo Esquelético/enzimologia , Animais , Temperatura Corporal/fisiologia , Metabolismo Energético/fisiologia , Regulação Enzimológica da Expressão Gênica/genética , Frequência Cardíaca/fisiologia , Isoenzimas , Locomoção/fisiologia , Camundongos , Camundongos Knockout , Microscopia Eletrônica , Contração Muscular/genética , Proteínas Musculares/análise , Músculo Esquelético/ultraestrutura , Mutação/genética , Miocárdio/ultraestrutura , Fosfatos/análiseAssuntos
Encefalomiopatias Mitocondriais/genética , Mutação , NAD(P)H Desidrogenase (Quinona)/genética , NADH NADPH Oxirredutases/genética , Cromossomo X , DNA Complementar , Complexo I de Transporte de Elétrons , Feminino , Humanos , Masculino , Encefalomiopatias Mitocondriais/metabolismo , NAD(P)H Desidrogenase (Quinona)/metabolismo , NADH NADPH Oxirredutases/metabolismo , RNA Mensageiro , Distribuição TecidualRESUMO
An apparently new cardioskeletal myopathy is reported in three unrelated families. Five infants were affected by rapidly progressive generalized muscle weakness, with onset shortly after birth, and dilated cardiomyopathy. All had generalized tremor (clonus) starting in the first week of life. The disease was lethal in all cases between 4 and 6 months. Muscle biopsy, performed in four of the five patients, showed a light microscopic pattern of small type I and normal-sized type II fibres. By electron microscopy small fibres were affected by myofibrillar disruption and swelling of organelles. Findings in blood and urine suggested a disturbance in energy metabolism but an extensive search for respiratory chain disorders and disorders of mitochondrial fatty acid oxidation in frozen muscle and cultured fibroblasts was negative. The findings support a new progressive autosomal recessive infantile cardioskeletal myopathy in which type I muscle fibres are preferentially affected.
Assuntos
Cardiomiopatia Dilatada/patologia , Fibras Musculares Esqueléticas/patologia , Debilidade Muscular/patologia , Músculo Esquelético/patologia , Cardiomiopatia Dilatada/genética , Cardiomiopatia Dilatada/metabolismo , Carnitina/metabolismo , Ácidos Graxos/metabolismo , Feminino , Humanos , Lactente , Masculino , Microscopia Eletrônica , Fibras Musculares Esqueléticas/metabolismo , Fibras Musculares Esqueléticas/ultraestrutura , Debilidade Muscular/genética , Debilidade Muscular/metabolismo , Músculo Esquelético/metabolismo , Músculo Esquelético/ultraestrutura , Miocárdio/metabolismo , Miocárdio/patologia , Miocárdio/ultraestrutura , Miofibrilas/metabolismo , Miofibrilas/patologia , Miofibrilas/ultraestrutura , Países Baixos , Oxirredução , Linhagem , Complexo Piruvato Desidrogenase/metabolismoRESUMO
Combined alteration of the pyruvate dehydrogenase complex and respiratory chain function is described in a 21 year-old male patient with overlapping MELAS (mitochondrial encephalomyopathy, lactic acidosis, and 'stroke-like' episodes) and Kearns-Sayre syndrome. Progressive external ophthalmoplegia, pigmentary retinopathy and right bundle branch block were present when he experienced the first 'stroke-like' episode at 18 years old. The A>G tRNALeu(UUR) point mutation at nucleotide 3243 of the mitochondrial DNA was predominant in muscle tissue (79%) and present, but at lower levels in fibroblasts (49%) and blood cells (37%). Biochemical analysis revealed diminished activities of pyruvate dehydrogenase (23%) and respiratory chain complexes I and IV (57%, respectively) in muscle, but normal activities in the fibroblasts. Immunochemical studies of the muscular pyruvate dehydrogenase components showed normal content of E1alpha, E1beta and E2 protein. Molecular screening of the E1alpha gene did not indicate a nuclear mutation. These observations suggest that mitochondrial DNA defects may be associated with altered nuclear encoded enzymes which are actively imported into mitochondria and constitute components of the mitochondrial matrix. Biochemical workup of mitochondrial disorders should not be restricted to the respiratory chain even if mitochondrial DNA mutations are present.